Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinolysin ointment with vacuum dressing for open wound management
IRCT20221112056478N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of plasmin in open wound (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Effect on wound size, Effect on wound depth and 1 more. Started Nov 2022; status: completed.
02
Drugs
plasmin
03
Conditions
open wound
Beyond the preview
Go deeper on IRCT20221112056478N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221112056478N1.